Home › Trial NCT00410774
Gemcitabine and Bevacizumab in Treating Patients With Pancreatic Cancer That Has Been Completely Removed By Surgery
- Trial IDNCT00410774
- StatusTerminated
- PhasePhase 1/2
- Study typeInterventional
- SponsorUniversity of California, San Francisco
- Enrollment20
- Start date2006-07
- ConditionsPancreatic Cancer
Enriched analysis
Parsed endpoints, structured eligibility, drug class and a plain-English summary — shown to verified visitors to prevent automated scraping.
Trial data from ClinicalTrials.gov (U.S. public domain) and ISRCTN (CC BY 4.0), used with attribution. TrialLens is an independent index, not affiliated with or endorsed by ClinicalTrials.gov, the NIH, or any trial sponsor. For research only — not medical advice.